Increased concentrations of extracellular adenosine are reached in ischemic or inflamed tissues but have also been detected inside tumoral masses. This latter finding may account for an important role of adenosine in the pathogenesis of tumors and its contradictory effects on cell survival and proliferation remain to be reconciled with the presence of specific adenosine receptor subtypes. This article reviews the pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line and the functional significance of their presence in a tumor cell type. We show that adenosine improves cell proliferation via A2A receptors while it arrests the cells at G1/G0 cell cycle phase through A3 stimulation. Furthermore, adenosine triggers a survival signal via A3 receptor stimulation while it simultaneously promotes cell death via A2A receptor activation, inducing a signaling pathway that involves protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs).

Adenosine Receptors and Human Melanoma / Merighi, S; Baraldi, P. G.; Gessi, S; Iannotta, V; Klotz, K. N.; Leung, E; Mirandola, Prisco; Tabrizi, M. A.; Varani, K; Borea, P. A.. - In: DRUG DEVELOPMENT RESEARCH. - ISSN 1098-2299. - 58:(2003), pp. 377-385. [10.1002/ddr.10181]

Adenosine Receptors and Human Melanoma.

MIRANDOLA, Prisco;
2003-01-01

Abstract

Increased concentrations of extracellular adenosine are reached in ischemic or inflamed tissues but have also been detected inside tumoral masses. This latter finding may account for an important role of adenosine in the pathogenesis of tumors and its contradictory effects on cell survival and proliferation remain to be reconciled with the presence of specific adenosine receptor subtypes. This article reviews the pharmacological and biochemical characterization of adenosine receptors in the human malignant melanoma A375 cell line and the functional significance of their presence in a tumor cell type. We show that adenosine improves cell proliferation via A2A receptors while it arrests the cells at G1/G0 cell cycle phase through A3 stimulation. Furthermore, adenosine triggers a survival signal via A3 receptor stimulation while it simultaneously promotes cell death via A2A receptor activation, inducing a signaling pathway that involves protein kinase C (PKC) and mitogen-activated protein kinases (MAPKs).
2003
Adenosine Receptors and Human Melanoma / Merighi, S; Baraldi, P. G.; Gessi, S; Iannotta, V; Klotz, K. N.; Leung, E; Mirandola, Prisco; Tabrizi, M. A.; Varani, K; Borea, P. A.. - In: DRUG DEVELOPMENT RESEARCH. - ISSN 1098-2299. - 58:(2003), pp. 377-385. [10.1002/ddr.10181]
File in questo prodotto:
File Dimensione Formato  
070.pdf

non disponibili

Tipologia: Documento in Post-print
Licenza: NON PUBBLICO - Accesso privato/ristretto
Dimensione 141.6 kB
Formato Adobe PDF
141.6 kB Adobe PDF   Visualizza/Apri   Richiedi una copia

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11381/2429305
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 10
social impact